Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 214

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Transfusion Requirements in Surgical Oncology Patients: A Prospective, Randomized Controlled Trial

Open access
Pinheiro de Almeida, Juliano, Vincent, Jean-Louis, Barbosa Gomes Galas, Filomena Regina, Pinto Marinho de Almeida, Elisangela, Fukushima, Julia T., Osawa, Eduardo A., Bergamin, Fabricio, Lee Park, Clarice, Nakamura, Rosana Ely, Fonseca, Silvia M. R., Cutait, Guilherme, Inacio Alves, Joseane, Bazan, Mellik, Vieira, Silvia, Vieira Sandrini, Ana C., Palomba, Henrique, Ribeiro, Ulysses, Crippa, Alexandre, Dalloglio, Marcos, del Pilar Estevez Diz, Maria, Kalil Filho, Roberto, Costa Auler, Jose Otavio, Rhodes, Andrew, Hajjar, Ludhmila Abrahao · 2015 · Anesthesiology

Abstract

Background: Several studies have indicated that a restrictive erythrocyte transfusion strategy is as safe as a liberal one in critically ill patients, but there is no clear evidence to support the superiority of any perioperative transfusion strategy in patients with cancer. Methods: In a randomized, controlled, parallel-group, double-blind (patients and outcome assessors) superiority trial in the intensive care unit of a tertiary oncology hospital, the authors evaluated whether a restrictive strategy of erythrocyte transfusion (transfusion when hemoglobin concentration <7 g/dl) was superior to a liberal one (transfusion when hemoglobin concentration <9 g/dl) for reducing mortality and severe clinical complications among patients having major cancer surgery. All adult patients with cancer having major abdominal surgery who required postoperative intensive care were included and randomly allocated to treatment with the liberal or the restrictive erythrocyte transfusion strategy. The primary outcome was a composite endpoint of mortality and morbidity. Results: A total of 198 patients were included as follows: 101 in the restrictive group and 97 in the liberal group. The primary composite endpoint occurred in 19.6% (95% CI, 12.9 to 28.6%) of patients in the liberal-strategy group and in 35.6% (27.0 to 45.4%) of patients in the restrictive-strategy group ( P = 0.012). Compared with the restrictive strategy, the liberal transfusion strategy was associated with an absolute risk reduction for the composite outcome of 16% (3.8 to 28.2%) and a number needed to treat of 6.2 (3.5 to 26.5). Conclusion: A liberal erythrocyte transfusion strategy with a hemoglobin trigger of 9 g/dl was associated with fewer major postoperative complications in patients having major cancer surgery compared with a restrictive strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aln.0000000000000511

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 214

Metadata

Authors
Pinheiro de Almeida, J., Vincent, J.-L., Barbosa Gomes Galas, F. R., Pinto Marinho de Almeida, E., Fukushima, J. T., Osawa, E. A., Bergamin, F., Lee Park, C., Nakamura, R. E., Fonseca, S. M. R., Cutait, G., Inacio Alves, J., Bazan, M., Vieira, S., Vieira Sandrini, A. C., Palomba, H., Ribeiro, U., Crippa, A., Dalloglio, M., del Pilar Estevez Diz, M., Kalil Filho, R., Costa Auler, J. O., Rhodes, A., & Hajjar, L. A.
Venue
Anesthesiology
Published
2015-01
Volume
122
Issue
1
Pages
29-38
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2030466615
Cited by
214
References
3
FWCI
17.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transfusion Requirements in Surgical Oncology Patients: A Prospective, Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/aln.0000000000000511
The paper
Pinheiro de Almeida, J., Vincent, J.-L., Barbosa Gomes Galas, F. R., Pinto Marinho de Almeida, E., Fukushima, J. T., Osawa, E. A., Bergamin, F., Lee Park, C., Nakamura, R. E., Fonseca, S. M. R., Cutait, G., Inacio Alves, J., Bazan, M., Vieira, S., Vieira Sandrini, A. C., Palomba, H., Ribeiro, U., Crippa, A., Dalloglio, M., . . . Hajjar, L. A. (2015). Transfusion Requirements in Surgical Oncology Patients: A Prospective, Randomized Controlled Trial. Anesthesiology. https://doi.org/10.1097/aln.0000000000000511

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.